Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics including 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics', and updated a location entry from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedNon-alcoholic fatty liver disease and MedlinePlus Genetics have been added as related topics on the page, linking to background information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved the MedlinePlus Genetics topic for Non-alcoholic fatty liver disease, decreasing genetic-topic coverage for this disease.SummaryDifference0.2%

- Check37 days agoChange Detected- Added a government funding notice and operating-status details, and a new MedlinePlus Genetics topic. - Updated revision from v3.1.0 to v3.2.0.SummaryDifference2%

- Check44 days agoChange DetectedRemoved several topics (including Drug Safety-related items and MedlinePlus Genetics content) and an older version tag; added a new version tag v3.1.0. Overall, this is a restructuring/update of topics and versioning with minimal impact on core page content.SummaryDifference0.3%

- Check51 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Non-alcoholic fatty liver disease.SummaryDifference0.2%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.